ӳ����ý

The ӳ����ý is designed for collaboration. Visitors will notice walls of glass that promote transparency, “living rooms” with casual seating for informal meetings, and writable, “whiteboard walls” stocked with dry erase markers for spontaneous brainstorming sessions. Some of these writable walls sport chemical formulas or structures and others detail new hypotheses. In the ӳ����ý’s 320 Charles Street building, however, members of the Genomics Platform have transformed one whiteboard wall into an essential management tool, known as the “Strategy Board."

As associate director of the ӳ����ý’s Center for the Science of Therapeutics (CSofT), award-winning hematologist at Dana-Farber Cancer Institute, and a recognized pioneer in open-source drug discovery (not that he would admit to it), Jay Bradner is something of a rock star in the field of chemical biology.

The Genotype-Tissue Expression (GTEx) Project set out five years ago to create a comprehensive atlas and open database of gene expression and gene regulation across human tissues. This month, it reports on its two-year pilot phase. 

Four faculty members of the ӳ����ý of MIT and Harvard are among 26 top biomedical researchers nationwide who will become Howard Hughes Medical Institute (HHMI) investigators this fall. Levi Garraway, Pardis Sabeti, Michael Laub, and Tobias Walther will receive long-term, flexible funding from HHMI, providing them the freedom to explore and follow their research ideas through to fruition.